Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$490.32 USD
-5.59 (-1.13%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $490.24 -0.08 (-0.02%) 5:44 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: AMC |
6/2024 | $2.79 | -434.29% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 16.10%. Look out for VRTX's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $2.79 per share, reflecting a year-over-year decrease of 28.28%.
Earnings History
Price & Consensus
Zacks News for VRTX
Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services